The “Chlamydia Infection Diagnostics and Therapeutics – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
The publisher brings years of research experience to the 9th edition of this report. The 284-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Global Chlamydia Infection Diagnostics and Therapeutics Market to Reach $1.9 Billion by 2027
Amid the COVID-19 crisis, the global market for Chlamydia Infection Diagnostics and Therapeutics estimated at US$1.4 Billion in the year 2020, is projected to reach a revised size of US$1.9 Billion by 2027, growing at a CAGR of 4.9% over the period 2020-2027.
Diagnostics, one of the segments analyzed in the report, is projected to record 5.1% CAGR and reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Therapeutics segment is readjusted to a revised 4.4% CAGR for the next 7-year period.
The U.S. Market is Estimated at $373.7 Million, While China is Forecast to Grow at 7.5% CAGR
The Chlamydia Infection Diagnostics and Therapeutics market in the U.S. is estimated at US$373.7 Million in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$394.4 Million by the year 2027 trailing a CAGR of 7.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 4.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR.
Competitors identified in this market include, among others:
- Abbott Laboratories, Inc.
- Becton, Dickinson and Company
- bioMerieux SA
- Bio-Rad laboratories Inc.
- Danaher Corporation
- DiaSorin SpA
- F. Hoffmann-La Roche AG
- Novartis AG
- Siemens AG
- Thermo Fisher Scientific, Inc.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Global Competitor Market Shares
- Chlamydia Infection Diagnostics and Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
- Total Companies Profiled: 44
For more information about this report visit https://www.researchandmarkets.com/r/4uavfc
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900